Selected research
Market Structure
Global Blue Eye Disease Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Blue Eye Disease Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Blue Eye Disease Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Blue Eye Disease Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Blue Eye Disease Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Blue Eye Disease Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Blue Eye Disease Vaccines include CAHIC, Ceva, Chopper Biology, DHN, MSD Animal Health, Boehringer Ingelheim, Qilu Animal and Ringpu Biology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Blue Eye Disease Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Blue Eye Disease Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Blue Eye Disease Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Blue Eye Disease Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.
Blue Eye Disease Vaccines Segment by Company
CAHIC
Ceva
Chopper Biology
DHN
MSD Animal Health
Boehringer Ingelheim
Qilu Animal
Ringpu Biology
Blue Eye Disease Vaccines Segment by Type
Live Vaccines
Killed Vaccines
Blue Eye Disease Vaccines Segment by Application
Piglets
Adult Pigs
Blue Eye Disease Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blue Eye Disease Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blue Eye Disease Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blue Eye Disease Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Blue Eye Disease Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blue Eye Disease Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blue Eye Disease Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Blue Eye Disease Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Live Vaccines
- Killed Vaccines
Applications
- Piglets
- Adult Pigs
Companies covered
- CAHIC
- Ceva
- Chopper Biology
- DHN
- MSD Animal Health
- Boehringer Ingelheim
- Qilu Animal
- Ringpu Biology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Blue Eye Disease Vaccines Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Blue Eye Disease Vaccines Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Blue Eye Disease Vaccines Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Blue Eye Disease Vaccines Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Blue Eye Disease Vaccines Market Dynamics
- 2.1 Blue Eye Disease Vaccines Industry Trends
- 2.2 Blue Eye Disease Vaccines Industry Drivers
- 2.3 Blue Eye Disease Vaccines Industry Opportunities and Challenges
- 2.4 Blue Eye Disease Vaccines Industry Restraints
3 Blue Eye Disease Vaccines Market by Manufacturers
- 3.1 Global Blue Eye Disease Vaccines Revenue by Manufacturers (2021-2026)
- 3.2 Global Blue Eye Disease Vaccines Sales by Manufacturers (2021-2026)
- 3.3 Global Blue Eye Disease Vaccines Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Blue Eye Disease Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Blue Eye Disease Vaccines Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Blue Eye Disease Vaccines Manufacturers, Product Type & Application
- 3.7 Global Blue Eye Disease Vaccines Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Blue Eye Disease Vaccines Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Blue Eye Disease Vaccines Players Market Share by Revenue in 2025
- 3.8.3 2025 Blue Eye Disease Vaccines Tier 1, Tier 2, and Tier 3
4 Blue Eye Disease Vaccines Market by Type
- 4.1 Blue Eye Disease Vaccines Type Introduction
- 4.1.1 Live Vaccines
- 4.1.2 Killed Vaccines
- 4.2 Global Blue Eye Disease Vaccines Sales by Type
- 4.2.1 Global Blue Eye Disease Vaccines Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Blue Eye Disease Vaccines Sales by Type (2021-2032)
- 4.2.3 Global Blue Eye Disease Vaccines Sales Market Share by Type (2021-2032)
- 4.3 Global Blue Eye Disease Vaccines Revenue by Type
- 4.3.1 Global Blue Eye Disease Vaccines Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Blue Eye Disease Vaccines Revenue by Type (2021-2032)
- 4.3.3 Global Blue Eye Disease Vaccines Revenue Market Share by Type (2021-2032)
5 Blue Eye Disease Vaccines Market by Application
- 5.1 Blue Eye Disease Vaccines Application Introduction
- 5.1.1 Piglets
- 5.1.2 Adult Pigs
- 5.2 Global Blue Eye Disease Vaccines Sales by Application
- 5.2.1 Global Blue Eye Disease Vaccines Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Blue Eye Disease Vaccines Sales by Application (2021-2032)
- 5.2.3 Global Blue Eye Disease Vaccines Sales Market Share by Application (2021-2032)
- 5.3 Global Blue Eye Disease Vaccines Revenue by Application
- 5.3.1 Global Blue Eye Disease Vaccines Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Blue Eye Disease Vaccines Revenue by Application (2021-2032)
- 5.3.3 Global Blue Eye Disease Vaccines Revenue Market Share by Application (2021-2032)
6 Global Blue Eye Disease Vaccines Sales by Region
- 6.1 Global Blue Eye Disease Vaccines Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Blue Eye Disease Vaccines Sales by Region (2021-2032)
- 6.2.1 Global Blue Eye Disease Vaccines Sales by Region (2021-2026)
- 6.2.2 Global Blue Eye Disease Vaccines Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Blue Eye Disease Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Blue Eye Disease Vaccines Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Blue Eye Disease Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Blue Eye Disease Vaccines Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Blue Eye Disease Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Blue Eye Disease Vaccines Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Blue Eye Disease Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Blue Eye Disease Vaccines Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Blue Eye Disease Vaccines Revenue by Region
- 7.1 Global Blue Eye Disease Vaccines Revenue by Region
- 7.1.1 Global Blue Eye Disease Vaccines Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Blue Eye Disease Vaccines Revenue by Region (2021-2026)
- 7.1.3 Global Blue Eye Disease Vaccines Revenue by Region (2027-2032)
- 7.1.4 Global Blue Eye Disease Vaccines Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Blue Eye Disease Vaccines Revenue (2021-2032)
- 7.2.2 North America Blue Eye Disease Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Blue Eye Disease Vaccines Revenue (2021-2032)
- 7.3.2 Europe Blue Eye Disease Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Blue Eye Disease Vaccines Revenue (2021-2032)
- 7.4.2 Asia-Pacific Blue Eye Disease Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Blue Eye Disease Vaccines Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Blue Eye Disease Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 CAHIC
- 8.1.1 CAHIC Company Information
- 8.1.2 CAHIC Business Overview
- 8.1.3 CAHIC Blue Eye Disease Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 CAHIC Blue Eye Disease Vaccines Product Portfolio
- 8.1.5 CAHIC Recent Developments
- 8.2 Ceva
- 8.2.1 Ceva Company Information
- 8.2.2 Ceva Business Overview
- 8.2.3 Ceva Blue Eye Disease Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Ceva Blue Eye Disease Vaccines Product Portfolio
- 8.2.5 Ceva Recent Developments
- 8.3 Chopper Biology
- 8.3.1 Chopper Biology Company Information
- 8.3.2 Chopper Biology Business Overview
- 8.3.3 Chopper Biology Blue Eye Disease Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Chopper Biology Blue Eye Disease Vaccines Product Portfolio
- 8.3.5 Chopper Biology Recent Developments
- 8.4 DHN
- 8.4.1 DHN Company Information
- 8.4.2 DHN Business Overview
- 8.4.3 DHN Blue Eye Disease Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 DHN Blue Eye Disease Vaccines Product Portfolio
- 8.4.5 DHN Recent Developments
- 8.5 MSD Animal Health
- 8.5.1 MSD Animal Health Company Information
- 8.5.2 MSD Animal Health Business Overview
- 8.5.3 MSD Animal Health Blue Eye Disease Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 MSD Animal Health Blue Eye Disease Vaccines Product Portfolio
- 8.5.5 MSD Animal Health Recent Developments
- 8.6 Boehringer Ingelheim
- 8.6.1 Boehringer Ingelheim Company Information
- 8.6.2 Boehringer Ingelheim Business Overview
- 8.6.3 Boehringer Ingelheim Blue Eye Disease Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Boehringer Ingelheim Blue Eye Disease Vaccines Product Portfolio
- 8.6.5 Boehringer Ingelheim Recent Developments
- 8.7 Qilu Animal
- 8.7.1 Qilu Animal Company Information
- 8.7.2 Qilu Animal Business Overview
- 8.7.3 Qilu Animal Blue Eye Disease Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Qilu Animal Blue Eye Disease Vaccines Product Portfolio
- 8.7.5 Qilu Animal Recent Developments
- 8.8 Ringpu Biology
- 8.8.1 Ringpu Biology Company Information
- 8.8.2 Ringpu Biology Business Overview
- 8.8.3 Ringpu Biology Blue Eye Disease Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Ringpu Biology Blue Eye Disease Vaccines Product Portfolio
- 8.8.5 Ringpu Biology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Blue Eye Disease Vaccines Value Chain Analysis
- 9.1.1 Blue Eye Disease Vaccines Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Blue Eye Disease Vaccines Production Mode & Process
- 9.2 Blue Eye Disease Vaccines Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Blue Eye Disease Vaccines Distributors
- 9.2.3 Blue Eye Disease Vaccines Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst